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ABSTRACT  
The application of photonic crystal surfaces for label-free bioimaging and sensing is 
presented. A label-free biosensor assay is used to monitor the density of cell attachment to the 
sensor surface, and to quantify changes in attached cell density induced by the introduction of 
plant extracts.  This image-based biosensor detection approach can effectively identify plant 
extracts with cytotoxic effects on cancer cells using only 500 cells per test. A library of sixty-one 
plant extract from Bangladesh is studied. We have also demonstrated that cell death in extract-
treated cells occurs via apoptosis. Next, we take a closer look at the cytotoxicity of extracts from 
a single genus – the Amoora genus, on a panel of five different cancer cell lines. The effect of 
the extraction method used in preparing the extract sample on cell cytotoxicity is explored. An 
ongoing project involving the screening of plant protein samples from Pakistan is then presented. 
In further work, the description of the photonic crystal biosensor used for a protein-
macromolecule binding assay is presented. A high-throughput screen aimed at identifying small 
molecule disrupters of protein-DNA binding is designed and executed. Both the cell-based assay 
and the protein-DNA based assay described here find important applications in the modern drug 
discovery process. 
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CHAPTER 1   
INTRODUCTION TO LABEL-FREE SENSING FOR PHARMACEUTICAL 
SCREENING 
  
The development of robust and sensitive biosensor assays is critical to screening that will 
allow the discovery of new leads. The expensive and long process of discovering new drugs for 
disease targets necessitates the development of cost-effective and reliable screening strategies 
that identify leads that are the starting point for a more focused approach to address the target. 
1.1 Cell Based Assays 
Cell-based assays are a crucial part of the preclinical drug discovery and validation 
process. The quantification of toxicity and selectivity of new therapeutic leads in both targeted 
and non-targeted cell populations is an important early step in a large screening campaign. This 
is typically done by measuring increased cell membrane permeability of dead cells through the 
use a dye or by measuring activity of mitochondria in live cells with a dye [1,2]. Such cell 
proliferation assays are traditionally endpoint assays, as they require the use of proprietary 
reagents which are often highly cytotoxic. Furthermore, such assays call for multi-step assay 
protocols and usually measure a bulk property of cell populations within microplate wells 
(absorbance, fluorescence, or luminescence measurements) rather than the properties of 
individual cells.  Cell-based assays with simpler experimental protocols that can be implemented 
in a high throughput fashion while providing quantitative information using a small number of 
cells/assay would provide benefits for screening at this stage of pharmaceutical research in terms 
of time and costs of evaluating potential drug compounds from a large library.  While label-free 
biosensors have found widespread use in biomolecular screening [3], they are beginning to find 
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application in cell-based screening due to the incorporation of sensors within standard format 
microplate wells [4,5].  Because biosensors measure changes in the attachment of cells to the 
transducer surface, they provide information that is different from optical microscopy because 
cells that are present on the biosensor surface will not register a signal unless they are attached to 
the surface.  Therefore, biosensors measure the interaction between cell surface integrins with 
biomolecular coatings applied to the sensor surface, and quantify cell surface attachment 
modulation due to changes in local environment. 
1.2 Biomolecular Assays 
 Significant advances have been made in the area of developing high throughput enzyme 
inhibition screens of large compound libraries. Such assays use substrates that provide a 
chromogenic or fluorescent readout. However, there remains a paucity of good high-throughput 
screens of small molecule ligands that disrupt protein-macromolecule interactions.  As such, 
protein-DNA and protein-RNA interactions are essential for many cellular processes such as 
transcription, translation, and apoptosis. The identification of such inhibitory compounds finds 
value in the investigation of many biological processes as well as potential therapeutics.  
Label-based assays require additional development to ensure the label does not block 
active sites or modify the conformation of a tagged molecule. The optimization of washing and 
blocking conditions, characterization of reagents used and in cases of fluorescent assays, the use 
of labware made from low autofluorescent material are additional aspects that need to be 
considered during development. A label-free approach reduces assay cost and complexity while 
providing more quantitative information with high throughput.  
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1.3 Label-free Optical Biosensors 
 Label-free detection using optical biosensors is implemented by probing changes in the 
dielectric permittivity in the detection area induced by the presence of an analyte [6]. While 
label-free detection can be implemented by the interrogation of other properties of the analyte 
(eg. surface acoustic wave devices that track changes in the mass of the analyte), optical 
biosensors are especially attractive because biochemical events can be interrogated without any 
direct physical connection to the sensor. This greatly enables the adaptation of optical biosensors 
to flexible, large scale sensing formats. 
 Surface plasmon resonance (SPR) based optical biosensors are currently a very popular 
optical sensing technique used in biological research. The SPR biosensing method is especially 
popular for characterizing the binding affinity between moieties. However, this powerful tool has 
several limitations. First, the system is complex and expensive because of the use of high-end 
optics. Second, SPR is performed in small arrays of flow cells, a format that cannot be used for 
large scale parallel detection. Third, surface plasmons have a large propagation distance on the 
order of 100 µm that limits the spatial resolution of this technique. 
 A new class of photonic crystal optical biosensors have been demonstrated for label-free 
detection of biochemical interactions and exhibit a mass density sensitivity resolution < 1pg/mm2 
while possessing a large dynamic range [4]. These sensors can be fabricated over large areas and 
incorporated into microplates for compatibility with existing fluid handling systems. The 
biosensor structure, shown in Figure 1.1, consists of a one-dimensional photonic crystal 
comprising a low refractive index grating surface that is coated with a high refractive index film. 
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Detailed descriptions of the working of this sensor and its accompanying detection instruments 
are presented in later chapters. 
1.4 Research Outline 
In this work, the application of photonic crystal surfaces for label-free bioimaging and 
sensing are presented. An assay is developed for monitoring the density of cell attachment to the 
sensor surface, and quantifying changes in attached cell density induced by the introduction of 
plant extracts.  First, a library of sixty-one plant extract from Bangladesh is screened for 
exploring their cytotoxic potential. Next, we take a closer look at the cytotoxicity of extracts 
from a single genus – the Amoora genus, on a panel of five different cancer cell lines. The effect 
of the extraction method used in preparing the extract sample on cell cytotoxicity is explored. An 
ongoing project involving the screening of plant protein samples from Pakistan is then presented. 
Finally, the use of photonic crystal biosensors to detect relatively low protein-DNA binding and 
the disruption of this binding in the presence of an inhibitor is studied.  
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1.5 Figures 
 
Figure 1.1. Photonic crystal biosensor schematic with period (Λ), high index coating thickness 
(thi) and grating step height (tstep) 
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CHAPTER 2   
SCREENING OF CRUDE PLANT EXTRACTS THAT INDUCE APOPTOSIS IN 
PANCREATIC CANCER CELLS 
 
2.1 Introduction  
         Pancreatic cancer is the fourth leading cause of cancer-related death in both sexes in 
the United States [7]. Although Gemcitabine is the current first-line chemotherapeutic 
administered for metastatic pancreatic cancer, this line of treatment has been met with limited 
survival and symptomatic outcomes [8,9], resulting in research interest in exploring improved 
treatment options. Recent studies on plant extracts with implications in pancreatic cancer 
treatment are indicative of the continued role that natural products play in the drug discovery 
process [10,11].  
Previous research has shown how large-scale changes in an immobilized cell population (such as 
cytotoxicity, proliferation, and apoptosis) can be quantified using biosensors without the use of dyes, 
stains, or any other reagent [12,13]. With the introduction of biosensors and readout instrumentation 
methods that enable high resolution images of cell attachment upon the biosensor surface, it is possible to 
monitor the attachment of individual cells and cell clusters. Data processing from biosensor-based cell 
attachment images enables quantitative determination of the rate of cell attachment, detachment, and 
chemotaxis. 
We have demonstrated the use of Photonic Crystal (PC) optical biosensors and an 
imaging detection instrument that provides images of the spatial distribution of biomolecular and 
cellular analytes attached to the PC surface [14].   PC biosensors are fabricated from plastic 
materials using nanoreplica molding methods, and incorporated into the bottom surfaces of 
standard format 96-, 384-, and 1536-well microplates [15].  The PC surface contains a grating 
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structure that is designed to reflect only a single wavelength of light when illuminated with a 
broad band of wavelengths.  The reflected wavelength increases due to the attachment of cells to 
the PC surface, and shifts in the reflected wavelength are monitored with a spectrometer.  
Because cells only increase the reflected wavelength on the PC surface at the specific locations 
where they have attached, an imaging spectrometer is capable of producing a spatial map of 
reflected wavelength versus position that enables visualization of cell attachment.   
         In this study, we demonstrate the use of PC biosensors as one of several methods used 
in a cell-based screen of plant extracts, in which the extracts are screened for their relative 
cytotoxicity with respect to pancreatic cancer cells. Label-free biosensor images are used to 
quantify cell proliferation changes that occur when a natural compound is introduced.   A three-
tiered screening system was designed to identify plant extracts that induced apoptosis in 
pancreatic cancer cell lines using a 56-member plant extract library from Bangladesh. First, all 
extracts were screened for their ability to induce death in the Panc-1 cell line using a PC 
biosensor assay. Next, extracts that showed cytotoxicity to Panc-1 cells in the PC assay were 
tested using a colorimetric MTT assay on three pancreatic cell lines (Panc-1, Mia-Paca2, and 
Capan-1). The results obtained by the MTT assay validated those obtained using the PC 
biosensor.  Finally, the compound that showed the highest cytotoxicity in all three cell lines was 
evaluated for its apoptotic activity via a caspase-3 quantification assay. 
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2.2 Materials and Methods 
2.2.1 Sensor and imaging instrument 
The photonic crystal biosensor is a narrow-band reflectance filter with nearly 100% 
reflectance efficiency. This sensor consists of a one-dimensional photonic crystal consists of a 
periodically modulated low refractive index grating structure coated with a high refractive index 
film. Such a sub-wavelength grating structure only allows the propagation of 0th diffracted orders 
while blocking all higher orders. This means that the biosensor can be designed to block the 
propagation of light of specific wavelengths and particular directions. When the sensor is 
illuminated with white light at normal incidence, this biosensor reflects a narrow band with a 
peak reflection referred to as peak wavelength value (PWV). The spectral location of this peak is 
modulated by changes in the refractive index of material deposited on the sensor that lie within 
the extent of the evanescent field. In this manner it is possible to detect cell attachments on the 
surface through changes in the dielectric permittivity with respect to the cell media. An 
important property of the PC sensor is that it does not allow lateral propagation of resonantly 
coupled light. Therefore, a single PC surface is capable of supporting a large number of 
independent biosensor measurements without optical crosstalk between adjacent sensor regions, 
enabling high spatial resolution measurement scanning across the sensor surface. 
   The photonic crystal biosensor containing a one-dimensional surface grating structure 
(period = 550 nm) is constructed using a UV curable polymer on continuous rolls of transparent 
polyester film (SRU Biosystems). A room-temperature replica molding process has been 
employed to produce these sensors on a large scale. First a silicon master wafer is patterned with 
the grating structure using deep-UV photolithography. After developing the photoresist, the 
grating is transferred to the master wafer using reactive ion etching. Next, this one dimensional 
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grating structure is transferred to the continuous rolls of plastic film by applying a UV-curable 
polymer layer between the silicon master wafer and a section of the transparent polyester sheet. 
This polymer conforms to the master grating and is cured using UV light.  The polymer adheres 
preferentially to the polyester sheet and is peeled away from the master wafer. This low 
refractive index grating is then coated with a layer of high refractive index TiO2. The completed 
sensor is cut to form sections that are adhered to the bottom of a standard 384-well microtiter 
plate. 
This imaging instrument (SRU Biosystems) measures the resonant PWV on a pixel-by-
pixel basis to generate a spatial map of the PWVs for the scanned area.  A schematic of this 
instrument is shown in Figure 2.1. Here, white light polarized in a direction perpendicular to the 
grating illuminates the sensor at normal incidence. Light reflected from the sensor is directed to 
the opening slit aperture at the input of an imaging spectrometer via a beam splitter and an 
imaging lens. Reflected light from a line on the sensor surface, containing the biosensor 
resonance signal, is diffracted by a diffraction grating to produce a spatially-resolved spectrum 
for each pixel in the line. The imaging spectrometer contains a two-dimensional CCD camera 
with 2048 x 512 pixels. Thus the line-image through the spectrometer slit is imaged onto 512 
pixels and a reflection spectrum with a resolution of 2048 wavelengths is acquired for each pixel.  
A peak finding algorithm finds the peak wavelength for each of 512 pixels from the associated 
spectrum.  In this manner, a PWV image of a line of 512 pixels is generated.  To generate a two-
dimensional image of the sensor, a motorized stage translates the sensor perpendicular to the 
imaged line in small increments.  The spatial separation between image lines is determined by 
the step size of the stage between each line acquisition. An image is created by assembling series 
of image lines through software. The maximum length of the image line is dictated by the size of 
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the CCD chip. The width of the image line is determined by the width of the entrance slit of the 
spectrometer.  The width of this entrance slit may be set at a desired value within a range from 6 
to 200 µm. The PWV pixel resolution, or the width of the imaged line for our work, was 6.4 µm. 
By traversing the area of the sensor in a serpentine tiling fashion, the positional PWV map for a 
large area is generated. In our case, each tile has a width of 3.45 mm along the image line 
direction. So the desired area is covered by translating the sensor in steps of 3.45 mm along the 
image-line direction.  
The imaging instrument measures PWV shifts in a microplate well on a pixel-by-pixel 
basis to generate PWV images of the whole well with a spatial resolution of 6.4µm x 6.4µm. To 
measure a shift in the PWV due to cell attachment, the sensor surface is scanned twice: before 
(called the baseline scan) and after cells have attached to the surface. Using software, the two 
images are aligned and the baseline scan is mathematically subtracted to determine the shift in 
PWV values due to cell attachment. This PWV shift is a measure of the density of cell binding as 
a function of position within the well. This method has been used to detect the attachment of 
individual cells, and for scanning large populations of cells in microplate wells [4,16]. With such 
an imaging method where we are monitoring PWV shifts, the sensor performance is not 
dependant on the uniformity of PWV response across the area that is being interrogated.    
2.2.2 Plant extracts 
Fifty-six plant extracts (Table 2.1) commonly used in Bangladeshi folk medicine were 
provided by Dr. R. Chowdary from the University of Dhaka, Bangladesh. The extraction 
methods used for each sample are listed in Table 2.1. Details of the extraction method have been 
described previously [17]. Stock solutions of the powdered dried extracts were prepared by 
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dissolution in ethanol. The extracts were then introduced to cells at a concentration of 100 µg/ml 
by diluting the extract stock solutions in cell culture media. The final concentration of ethanol in 
these dilutions was no more than 0.5% (v/v) to minimize potential solvent effects on cell growth. 
Doxorubicin hydrochloride (DOX) and Curcumin (Cur.), used as positive controls, were 
purchased from Sigma Aldrich. 
2.2.3. General cell culture methods 
Three human pancreatic carcinoma cell lines were used in this study: Panc-1, derived 
from a mostly differentiated carcinoma [18]; MIA PaCa-2 (referred to as MIA), derived from an 
undifferentiated tumor in the pancreas [19]; and Capan-1, derived from liver metastases of a 
well-differentiated tumor [20]. All cell lines were obtained from ATCC (Rockville, MD, USA).  
Cell lines were grown at 37oC and 5% CO2 in sterile DMEM medium with 10% fetal bovine 
serum (Panc-1), DMEM with 10% fetal bovine serum and 2.5% horse serum (MIA), and IMDM 
with 20% fetal bovine serum (Capan-1), after the addition of 4mM L-glutamine and penicillin-
streptomycin. Cells were grown in standard tissue culture flasks and upon reaching 80% 
confluence were passaged with a solution of 0.25% trypsin-EDTA. 
2.2.4. PC biosensor-based cell attachment assay 
The effect of each plant extract on the Panc-1 cell line was determined in an initial screen 
using a label-free PC biosensor-based assay. An initial baseline PWV scan was first taken in 
which each biosensor microplate well contained 25 µL cell culture media. The media was 
aspirated and the cells were then plated into the wells of a 384-well biosensor microplate at a 
density of approximately 500 cells/well and allowed to attach overnight at 37oC. A second scan 
was taken after cell attachment and the PWV shift image was determined by subtracting the 
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baseline image from the post-attachment image. The post-attachment scan was taken to assess 
cell plating uniformity. The cells were then incubated for 24 hours with 25 µL of extract in 
media at a final concentration of 100 µg/mL. Control cultures and blank wells without cells 
received 100 µL of medium with 0.5% (v/v) of ethanol. After the 24 h drug exposure period, the 
cells were grown for an additional 24h in extract-free fresh medium. A final post-treatment scan 
was then taken and the PWV shift image was determined by subtracting the baseline image from 
the post-treatment image. Increases in the local PWV as registered by the local pixels were 
observed only in regions where cells formed a close physical attachment to the sensor surface. 
Dead cells and other debris that are physically deposited on the same surface did not register 
similar increases in the local PWV. Estimates of the number of the cells that were attached to the 
sensor surface in each well were made using a PWV shift threshold as described earlier [12]. 
Briefly, a histogram of every pixel’s PWV shift value in each image of a single well is generated. 
A threshold PWV shift is selected so as to differentiate pixels with little or no PWV shift 
(representing pixels upon which no cell is attached) from pixels with a substantial PWV shift 
(representing pixels where cells have attached). Each pixel with a PWV greater than the 
threshold value is counted as a cell, because the pixel size is roughly equivalent to the diameter 
of a pancreatic cancer cell. A threshold value of ∆PWV= 2 nm was used for the measurements 
reported here.  Cell counts were determined for all wells after incubation with the extracts and 
proliferation was expressed as the fraction of treated cells that survived relative to untreated 
cultures. Every experiment included a set of negative controls (untreated cultures) as well as two 
sets of positive controls (DOX and Curcumin). All experiments were performed once in 
triplicates.   
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2.2.5. MTT proliferation assay 
Changes in proliferation rates of the three cell lines, when exposed to the plant extracts, 
were determined using the ATCC MTT Cell Proliferation Assay kit. The assay, previously 
described in [21] is based on the conversion of yellow tetrazolium salt MTT to purple formazan 
crystals by metabolically active cells. The amount of formazan produced is proportional to the 
number of viable cells. 
  Cells were plated in 96-well flat bottom tissue culture plates at a density of approximately 
1-1.2 x 104 cells/well and allowed to attach overnight at 37oC. The cells were then incubated 
with 100 µL of extracts at a concentration of 100 µg/mL for 24 hours. Untreated cultures and 
blank wells without cells received 100 µL of medium with 0.5% (v/v) of ethanol. After the drug 
exposure period, the cells were grown for an additional 24 hours in extract-free fresh medium. 
Next, 10 µL of the MTT reagent was added to each well, and the plate was incubated for 4 hours 
at 37oC. The MTT crystals were then solubilized overnight by adding 100 µL of the MTT 
detergent reagent to each well. Absorbance measurements were made at 570 nm using a Biotek® 
Synergy HT Spectrophotometer. Proliferation was expressed as the fraction of treated cells that 
survived relative to untreated cultures. The IC-50 values were calculated using GraphPad Prism 
5.0 (GraphPad Software Inc., San Diego, CA). Every experiment included a set of negative 
controls (untreated cultures) as well as two sets of positive controls (DOX and Curcumin). All 
experiments were performed in triplicates and repeated at least twice. 
2.2.6. Caspase-3 activity quantification assay 
Caspase-3 activity was assessed using the caspase-3 Colorimetric Assay Kit (Sigma 
Aldrich) as described in [22].  This assay is based on the detection of the amount of Ac-DEVD-
14 
 
pNA cleaved by cell lysates to release the colored pNA molecule. To accomplish this, PANC-1 
cells were exposed to the plant extract or Staurosporine, a known apoptotic agent. Following 
treatment, the cells were washed in PBS and the cells were suspended in a lysis buffer (50mM 
HEPES pH 7.4, 5mM CHAPS, 5mM DTT) for 15 minutes at a concentration of 107 cells per 
100µL of buffer. Lysed cells were centrifuged at 16,0000 x g, 4oC for 15 minutes. Lysate protein 
concentrations were determined using the Bradford assay. Equal amounts of protein (~ 20µg) 
from each sample were used to determine caspase-3 activity according to the. The optical density 
was measured at 405nm in a Biotek® Synergy HT Spectrophotometer. The amount of Ac-
DEVD-pNA cleaved was calculated and plotted. All experiments were performed in duplicates 
and repeated at least twice. 
2.2.7 Morphological Evaluation with Optical and Fluorescence Microscopy 
The morphology of untreated (negative control), Staurosporine (positive control) treated 
cells, and cells treated with a plant extract P. Punctata was studied using optical microscopy. In 
a separate experiment, the DNA of cells with the different treatments was stained with Hoechst 
33342 (Sigma) and observed using fluorescence microscopy.  For both experiments, 
approximately 5 x 104 cells/well  Panc-1 cells were seeded in 3mm dishes and allowed to attach 
overnight. The cells were then incubated with media, with 0.1µg/ml of Staurosporine, or with 
100µg/ml of P. Punctata  for two hours. The cells were subsequently washed with PBS. One set 
of cells was imaged under brightfield for observing treatment induced morphological changes 
using a Fisher scientific Micromaster inverted optical microscope fitted with a Canon Powershot 
S5 1S camera. The second set of cells was treated with 20µg/ml Hoechst 33342 for 15 minutes at 
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room temperature in the dark. Morphological changes in the DNA were examined using a Nikon 
Eclipse E600FN fluorescence microscope fitted with a Pixera Penguin 600CL camera. 
2.2.8. Statistical Analysis 
Results were expressed as means ± SD of replicate analyses. Comparison between data 
sets were performed using one way analysis of variance (ANOVA) followed by Student’s t-test. 
All statistical analyses were performed using GraphPad Prism 5.0 (GraphPad Software Inc., San 
Diego, CA). Differences were accepted as significant at p < 0.05. 
2.3 Results 
2.3.1 Plant extracts induce cell death  
     An initial screen of fifty-six extracts was performed on the Panc-1 cell line using the PC 
biosensor-based cell attachment assay. Biosensor images of representative individual wells of a 
384-well biosensor microplate before and after treatment are shown in Figure 2.2.  Here, the 
PWV shift as a function of position is represented as a false color image. In each image, a pixel 
represents a 6.4 µm x 6.4µm region of the sensor surface. Figure 2.2a. shows the PWV shift 
images of an untreated control well taken before (top image) and after (bottom image) the 
treatment period. Figures 2.2b-c show PWV shift images of the two positive control wells, DOX 
and Curcumin, taken before (top image) and after (bottom image) the treatment period. Figure 
2.2d. shows PWV shift images of an extract-treated well where nearly 100% cell death was 
observed. Finally, Figure 2.2e. shows PWV shift images of an extract-treated well where the 
extract enhanced cell proliferation. Using the thresholding method, the number of cells in each 
well after the initial seeding period was determined from the top PWV shift image. After the 
treatment period, cell counts for each well were obtained from the bottom PWV shift image and 
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counts from treated wells were compared against those from untreated control wells present on 
the same plate. The data from PWV shift images of the 56 extracts were converted into cell 
survival fractions relative to untreated wells as shown in Figure 2.3a. Several of the plant 
extracts induced cell death at 100 µg/mL in Panc-1 cells. The nine most potent extracts that 
induced over 95% cell death are shown in Figure 2.3b.  
     These nine extracts identified in the PC-based screen were tested using the MTT assay on 
the Panc-1 cell line in addition to the Capan-1, and MIA cell lines. All nine extracts induced over 
90% cell death in the Panc-1 line as observed in the PC-based screen. Four of these extracts also 
induced death in the MIA and Capan-1 cell lines (Figure 2.4a). Two extracts - P. punctata (No. 
34) and A. sessilis (No. 4) were found to induce over 95% cell death in all three cell lines. Dose 
response studies of P. punctata and A. sessilis on Panc-1 and MIA cells showed that inhibition 
was concentration-dependant (Figure 2.4b). P. punctata was found to be most potent at killing 
Panc-1 cells. The IC-50 values of P. punctata and A. sessilis are summarized in Table 2.2. 
2.3.2 Extract induces apoptosis  
   Caspase-3 activation is a crucial component in the apoptotic signaling cascade. This 
experiment assessed whether the observed death from P. punctata (No. 34) was due to apoptosis.  
Our results in Figure 2.5a show that treatment of Panc-1 cells with P. punctata strongly induces 
increased caspase-3 activity. Figure 2.5b shows that the caspase-3 activity observed was similar 
to that observed with Staurosporine-treated cells. In contrast, untreated controls maintained a 
basal caspase-3 activity. Furthermore, caspase-3 activity in P. punctata-treated cells was 
inhibited in the presence of a caspase-3 specific inhibitor. This suggests the involvement of 
caspase-3 in triggering apoptosis in P. punctata-treated Panc-1 cells. 
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2.3.3 Extracts induce cell morphological changes  
Brightfield images revealed no membrane blebbing  in non-treated cells (Figure 2.6a). 
However, treating Panc-1 cells with P. punctata for only 2 h had dramatic effects on cell 
proliferation as well as cell morphology. Upon extract exposure, microscope images revealed 
that most cells were detached from the culture dish surface. Furthermore, extract treated cells 
showed apoptotic morphology characterized by membrane blebbing and cell shrinkage, similar 
to those cells treated with Staurosporine, a known apoptosis inducer (Figure 2.6b-c).   
Fluorescence microscopy revealed slight Hoechst 33342 staining in non-treated cells with 
and no apoptotic nuclei were observed (Figure 2.7a). In contrast, treatment with P. punctata for 2 
h altered Panc-1 cell morphology. Many hoechst stained cells exhibited typical apoptotic 
morphology characterized by chromatin condensation and DNA fragmentation (Figure 2.7b). 
Similar morphology was observed in Stuarosporine treated cells (Figure 2.7c). 
2.4 Discussion  
    Due to the high mortality rates of pancreatic cancer and the absence of effective 
chemotherapy, there is a continued need for new alternatives for treatment and prevention, and 
natural products play a dominant role in the discovery of such new drugs, as over 60% of 
approved drugs or those in late stages of development (during 1989-1995) are of natural origin 
[23]. Examples of clinically useful antitumor agents derived from plants include pacitaxel, 
vincristine, and camptothecin, and many other plant-derived anticancer agents have been 
discovered through large-scale screening programs [24]. In this work, we have demonstrated 
how a label-free biosensor assay can be used to identify new natural-product based leads. Three 
human pancreatic adenocarcinoma cell lines (Panc-1, MIA, and Capan-1) that best represent an 
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in-vitro model were studied due to their reported low sensitivity to a current treatment agent 
(gemcitabine) and for their expression of multiple drug resistant proteins [25-28] .  
   This label-free technique used to screen the library for plant extracts which inhibited 
growth of pancreatic cancer cells has revealed that among fifty-six extracts, one extract showed 
significant cytotoxicity to the three lines that were tested . A traditional colorimetric proliferation 
assay was used to confirm our findings from the screen   (Figure 2.2-2.4). Morphological 
changes observed in treated cells suggested the induction of cellular apoptosis, which was 
affirmed by a biochemical assay that showed increased expression of caspase-3 protein in cells 
treated with P. punctata (Figure 2.5-2.7). 
    Interestingly, this study does not represent the first instance in which the species P. 
punctata (a member of the the Solanaceae family) has been associated with potential 
pharmacological activity. The results of a phytochemical screening of the methanolic extract of 
P. punctata showed the presence of steroids as an active component [17]. Several species of the 
Solanaceae family are used for the treatment of infections and skin disorders [29]. A previous 
study has reported the strong antimicrobial activity of P. Punctata. [30]. In addition, separate 
studies have reported the antiproliferative activity of species from the Solanaceae family on 
several human cancer cell lines [31,32]. 
   Based on the findings presented here, the isolation and characterization of the active 
ingredients in P. punctata responsible for its antiproliferative property is warranted. Experiments 
that elucidate the extract’s mechanism of action are also critical to the continued investigation of 
this potential therapeutic agent.  
19 
 
   There are several advantages to using the PC biosensor system in high-throughput cell-
based screening assays. Since the biosensors are incorporated into microplates, they can be used 
with standard microplate liquid handling instrumentation such as pipetting systems and wash 
stations. Furthermore, assays using as few as 500 Panc-1 cells per well in a 384-well plate can be 
performed, which is particularly important for cell lines that proliferate slowly. A comparable 
colorimetric based MTT proliferation assay requires 2500-3000 cells per well. Although the 
assays shown in this work utilize cells that readily attach to the biosensor surface without the use 
of specific capture molecules, previous work has also demonstrated the use of PC biosensors for 
cells that would ordinarily remain suspended in solution by preparing the biosensor with 
immobilized proteins that specifically bind with outer membrane proteins. [4]. Using the imaging 
capabilities reported here, it is possible to capture images of individual cells and cell clusters, 
and to observe the qualitative effect of a therapeutic agent on each as a function of time. Since 
PC biosensor assays are label-free, cells are not stained, killed, or altered in any way.  Hence, it 
is possible to use the biosensor to perform proliferation assays, and to subsequently use the same 
cells to interrogate the presence of a protein, such as caspase-3. Caspase 3 protein detection and 
quantification can be performed using commercially available kits designed to work directly with 
cultures of adherent cells. One such test (Caspase-Glo ®) uses a single reagent to perform both 
the cell lysis and the caspase cleavage of a substrate leading to the generation of luminescence, 
which is detectable using any standard microplate-compatible spectrophotometer.  
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2.5 Tables 
Table 2.1 
 
The names of the 56 plant extracts that were tested and their method of extraction are listed 
here. 
 
ID No. Plant Species Extract/partitionate 
1 Aglaia roxburghiana n-Hexane partitionate of MeOH extract 
2 Alternanthera sessilis Pet-ether fraction of MeOH extract 
3 Alternanthera sessilis MeOH residue of MeOH extract 
4 Alternanthera sessilis CHCl3 fraction of MeOH extract 
5 Amoora chittagonga Pet-ether partitionate of MeOH extract 
6 Amoora chittagonga CHCl3 partitionate of MeOH extract 
7 Amoora chittagonga EtOAc partitionate of MeOH extract 
9 Amoora rohituka Pet-ether extract 
10 Amoora rohituka MeOH extract 
11 Anisoptera glabra MeOH extract 
12 Anogeissus latifolia EtOH extract 
13 Anogeissus latifolia MeOH extract 
14 Brunfelsia latifolia MeOH extract 
15 Buchanania lanzen MeOH extract 
16 Bursera serrata Pet-ether extract 
17 Bursera serrata Dichloromethane extract 
18 Chukrasia tabularis MeOH extract 
19 Cinnamomum zeylanicum MeOH extract 
20 Citrus hystrix MeOH extract 
21 Combretum coccineum 
CHCl3 partitionate of acidified MeOH 
extract 
22 Combretum gradiflorum MeOH extract 
23 Eclipta prostata MeOH extract 
24 Eiroglossum edule MeOH extract 
25 Ficus sp. MeOH extract 
26 Garuga pinnata MeOH extract 
27 Indigofera tinctoria EtOH extract 
28 Lannea coromandelica MeOH extract 
29 Nephelium litchi MeOH extract 
30 Nephelium longum MeOH extract 
31 Pesprum nocturnum MeOH extract 
32 Petunia meleagris MeOH extract 
33 Petunia phoenica MeOH extract 
34 Petunia punctata MeOH extract 
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ID No. Plant Species Extract/partitionate 
35 Petunia violaceae MeOH extract 
37 Phyllanthus reticulatus CHCl3 fraction of pet-ether extract 
38 Phyllanthus reticulatus Hexane fraction of CH2Cl2 extract 
39 Phyllanthus reticulatus Acidified CHCl3 fraction of aqueous extract 
40 Phyllanthus reticulatus Acetone extract 
41 Poivrea coccinea MeOH extract 
42 Pongamia glabra MeOH extract 
43 Protium serratum MeOH extract 
44 Pterospermum suberifolium MeOH extract 
45 Quisqualis indica Pet-ether extract 
46 Quisqualis indica MeOH extract 
47 Sapindus mukkurossi MeOH extract 
48 Semecarpus anacardium MeOH extract 
49 Shorea robusta EtOH extract 
52 Spondias mangifera MeOH extract 
53 Swintonia floribunda MeOH extract 
54 Terminalia bellerica MeOH extract 
55 Terminalia bellerica MeOH extract 
56 Trachspermum ammi EtOH extract 
57 Xanthoxylum budrunga MeOH residue of MeOH extract 
59 Xylocurpus mollucensis n-Hexane partitionate of MeOH extract 
60 Xylocurpus mollucensis MeOH residue of MeOH extract 
61 Zizphus jujuba MeOH extract 
 
Table 2.1 continued 
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Table 2.2 
IC50 values of P. punctata (No. 34) and A. sessilis (No. 4) for pancreatic cancer cell lines 
Cell Line IC50 (µg/mL) 
P. punctata (Extract No. 34) A. sessilis (Extract No. 4) 
Panc-1 8.7 41.6 
MIA 73.96 54.4 
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2.6 Figures 
 
 
 
 
Figure 2.1. Schematic diagram of label-free imaging system
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Figure 2.2. PWV shift images in false color with shift scale bars indicating the magnitude of 
wavelength shift in nanometers. Pixels with higher PWV, displayed in brighter colors, indicate 
locations where Panc-1 cell attachment has occurred. The five image sets represent the following 
(a) Untreated control, (b) positive control (DOX), (c) positive control (Curcumin), (d) extract 
that induced maximum cell death (P. punctata, No. 34), (e) extract that enhanced proliferation    
( A. glabra, No. 11). In each image set, the top image was taken before exposure and the bottom 
image was taken after the 24 hour exposure period with a plant extract or positive control at 
100µg/ml. Scale bar (white) = 500 µm 
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Figure 2.2 (cont.) 
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(a) 
 
(b) 
 
 
Figure 2.3. (a) 56 plant extracts screened for their ability to induce Panc-1 cell death. DOX and 
Curcumin are the positive controls. Several extracts induced cell death at 100ug/ml in Panc-1 
cells. (b) Nine extracts were found to induce >95% cell death. Screening was performed by the 
PC-biosensor based assay. 
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Figure 2.4. Four plant extracts (Nos. 4, 6, 34, and 41) were able to suppress proliferation in all 
three pancreatic cancer cell lines. After seeding the cells in a 96-well plate, they were treated 
with 100 µg/ml of the extract for 24h (a). The two most potent extracts (Nos. 34 and 4) 
suppressed proliferation of Panc-1 and MIA cells in a dose dependant manner (b). Cell viability 
was assessed by the MTT assay. 
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Figure 2.5. (a) Caspase-3 activity of Panc-1 cells treated with 100 µg/ml of P. punctata (No. 34). 
(b) Caspase-3 activity of lysates from untreated, 34 treated, and Staurosporine treated Panc-1 
cells in the absence and presence of a caspase-3 inhibitor. Treatment period lasted three hours.  
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Figure 2.6. Panc-1 cell morphological alterations after 2 hours of P. punctata treatment as revealed in this 
brightfield image. Panc-1 cells were treated with (a) cell medium (control), (b) 100 µg/ml P. punctata or 
(c) 0.1 µg/ml of Staurosporine. Membrane blebbing and cell shrinkage was observed (arrows) indicating 
the occurrence of apoptosis. 
 
 
 
 
 
 
 
 
Figure 2.7. Panc-1 nuclear morphological alterations after 2 hours of P. punctata treatment as revealed in 
this fluorescence image where the cell DNA has been stained. Panc-1 cells were treated with (a) cell 
medium (control), (b) 100 µg/ml P. punctata or (c) 0.1 µg/ml of Staurosporine. DNA condensation was 
observed (arrows) indicating the occurrence of apoptosis. 
 
                         a               b           c 
                    a                b                       c 
                 Control      P. Punctata   Staurosporine 
                   Control      P. Punctata     Staurosporine 
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CHAPTER 3  
CYTOTOXICITY STUDY OF AMOORA PLANTS ON PANEL OF CANCER CELLS  
 
3.1 Introduction 
Several species of the Amoora plant extract in many parts of Bangladesh possess 
medicinal properties against inflammation, cancer and diseases of the liver [33].  One of the 
species, the Amoora rohituka grows wildly in the region and are planted in many districts of 
Bangladesh [34].  The petroleum ether and methanol extracts of A. rohituka are reported to 
possess good laxative potential as well as antimicrobial activity [35].  Furthermore, the plant 
titerpenic acid, Amooranin, extracted from the bark of Amoora rohituka trees has been reported 
to possess significant anticancer potential [36]. Amooranin has been shown to induce apoptosis 
in breast carcinoma through caspase activity [37], and is known to be effective against a broad 
panel of cancers such as breast, colon, cervical and leukemia [38].   
While studies have reported that the Amoora rohituka extract is effective against several 
cancer cell lines, we would like to examine the effect of other species of the Amoora family on 
different cancer cell types. Furthermore, we would like to explore the effect, if any, of the 
method of extraction on the sample’s cytotoxic potential to cancer cells. 
In this work, a single class of compounds of the genus Amoora, from our library of 
extracts from Bangladesh, is explored for their anticancer potential on two different categories of 
cancer cells, breast cancer cells: MCF-7 and HTB-126 cancer cell lines, and pancreatic cancer 
cells: Panc-1, Mia-Paca2, and Capan1 cancer cell lines.  We aim to focus on two different 
species of Amoora (Amoora chittagonga and Amoora rohituka) that have been fractionated with 
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different solvents (Pet-Ether, Methanol (MeOH), chloroform (CHCl3), and Ethyl Acetate 
(EtoAC)).  Dose response studies of each of these samples on the five cell lines are performed 
via MTT assays and the results were correlated and confirmed with a photonic crystal assay.   
3.2. Materials and Methods:  
3.2.1 Cancer Cell Lines and Plant Extracts 
Two cell lines of the breast cancer cells (MCF-7 and HTB126) and three cell lines of the 
pancreatic cancer cells (Panc-1, Mia-Paca2, and Capan1) were examined.  The five cell lines 
were purchased from ATCC (Rockville, MD, USA).  The cells were cultured and grown at 37oC 
and 5% CO2 in sterile DMEM medium with 10% fetal bovine serum (MCF-7, HTB126, and 
Panc-1), DMEM with 10% fetal bovine serum and 2.5% horse serum (Mia-Paca2), and IMDM 
with 20% fetal bovine serum (Capan1), after the addition of glutamine and penicillin-
streptomycin.  Cells were grown in standard tissue culture flasks and upon reaching 80% 
confluence were passaged with a solution of 0.25% trypsin-EDTA.  
Plant extracts from the species Amoora chittagonga and Amoora rohithuka were 
provided by Dr. R Chowdary from the University of Dhaka, Bangladesh.  Stock solutions of the 
dried extracts were prepared by dissolving them in ethanol.  These stock solutions were at 
concentrations of 25 mg/ml or higher.  These extract stock solutions were diluted directly in cell 
culture media and tested on cells at concentrations of 10, 25, 50, 100 µg/ml.  The final 
concentration of ethanol in all dilutions was less than 1%. 
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3.2.2 Cytotoxicity Analysis with MTT Assay 
Cytotoxicity of the plant extracts on the cell lines was determined using the ATCC MTT 
Cell Proliferation Assay kit and also the MTT assay kit from Sigma Aldrich.  The assay is based 
on the conversion of yellow tetrazolium salt MTT to purple formazan crystals by metabolically 
active cells. The amount of formazan produced is proportional to the number of viable cells.  The 
detailed description of the MTT experimental protocol has been presented on page 13. All MTT 
experiments were repeated twice. 
3.2.3 Cytotoxicity Analysis with Photonic Crystal Biosensor 
A 96-well TiO2 coated PC biosensor microplate was utilized to correlate and confirm the 
cytotoxicity effect of the Amoora extracts on the breast cancer cell MCF-7. An imaging 
resolution of 22.3 µm was used for this work.  An initial scan with the cell culture media was 
taken for the background image.  Approximately 1000 cells were seeded in the biosensor and the 
cells were allowed to attach and grow for 24 hours.  A second scan was performed after the 24-
hour incubation.  The cells were incubated with the plant extracts at the same concentrations as 
the MTT assay for another 24 hours after which, a final scan was performed.  A detailed 
description of the photonic crystal cell-based method has been presented on page 12.  
3.3 Results 
The extracts were tested at four different concentrations, 10, 25, 50 and 100 µg/mL on 
five cancer cell lines.  The dose-dependent responses for the breast cancer cells are shown in 
Figure 3.1.  For the MCF-7 cancer cell line (Figure 3.1a), A. chittagonga species had an IC50 of 
~42 µg/ml and 48 µg/ml for the Pet-Ether and CHCl3 extracts, respectively.  The Pet-Ether 
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extract of A. rohituka showed an IC50 of approximately 41 µg/ml for MCF-7 cells.  However, the 
EtoAC extract of A. chittagonga and the MeOH extract of A. rohituka did not affect MCF-7 
proliferation.  For the HTB126 cancer cell line (Figure 1b), only the CHCl3 extract of A. 
chittagonga showed significant cytotoxicity with an IC50 of ~43 µg/mL. 
The dose response curves for the pancreatic cancer cells are shown in Figure 3.2.  For the 
Panc-1, Mia-Paca2, and Capan-1 cancer cell lines (Figure 3.2a-c), only the CHCl3 extract of A. 
chittagonga showed significant cytoxicity with IC50 values of ~39 µg/ml, 30 µg/ml, and 65 
µg/ml, respectively.    
Dose response results obtained with the photonic crystal biosensor system were 
consistent with the results obtained using the MTT assay. The Pet-Ether and CHCl3 fractions of 
A.chittagonga, and Pet-Ether fraction of A.rohituka showed IC50 values at ~40 µg/ml, 51 µg/ml, 
and 38 µg/ml, respectively in MCF-7 cells.  The other two extracts, chittagonga EtoAC and 
rohituka MeOH enhanced cell proliferation.   
There was very good correlation between the dose response studies using the photonic 
crystal assay and the MTT assay for the fractions of Amoora compounds that were cytotoxic to 
MCF-7 cells.  The correlation plots are shown in Figure 3.3.  For the Pet-Ether and CHCl3 
fractions of A.chittagonga, and the Pet-Ether fraction of A. rohituka, the correlation coefficients 
for MCF-7 cells are 0.909, 0.715, and 0.922, respectively. Table 3.1 summaries the IC50 values 
that were measured for all the extracts tested on the five cell lines. 
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3.4 Discussion 
Among the three different A. Chittagonga fractionates tested, the CHCl3 extract of A. 
Chittagonga was found to show significant cytotoxicity to both breast cancer cell lines as well as 
the three pancreatic cancer cell lines tested. The pet-ether extract of A. Chittagonga was 
cytotoxic only to MCF-7 cells while the EtoAC extract of A. Chittagonga had no cytotoxic effect 
on any of the cell types. 
The pet-ether extract of A. rohituka was found to be highly cytotoxic to MCF-7 cells. 
This is in agreement with previous studies in the literature. However, we found that the methanol 
extract of A. Rohituka had no cytotoxic effect on any of the cells tested. 
Our results suggest that the extraction method used in preparing the A. rohituka and A. 
chittagonga samples has an effect on the sample’s cytotoxicity to breast and pancreatic cancer 
cells.  Furthermore, we found that the chloroform extract of A. chittagonga is cytotoxic to a wide 
range of cell types. It is important to separate and characterize the active ingredients of this 
extract to identify the cytotoxicity mechanism. Future work to elucidate the path of cell death in 
treated cells is also crucial. It is also important to understand how the extraction method affects 
the sample’s ability to arrest cancer cell proliferation. Finally, for such a plant extract to be a 
viable cancer therapeutic, it is important to study the toxicity effect of this extract on normal 
cells. An ideal therapeutic candidate will be highly selective in killing most of the cancerous 
cells in a given cell population with minimal damage to normal cells.  
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3.5 Tables 
Table 3.1.  The IC50 values of five Amoora plant extracts on the five cancer cell lines.  
 Amoora Species 
(Extraction 
Method) MCF-7 HTB126 Panc-1 Mia-Paca2 Capan-1 
chittagonga     
(Pet-Ether) 
42 µg/ml No Effect No Effect No Effect No Effect 
chittagonga 
(CHCl3) 
48 µg/ml 43 µg/ml 39 µg/ml 30 µg/ml 65 µg/ml 
chittagonga 
(EtoAC) 
No Effect No Effect No Effect No Effect No Effect 
rohituka         
(Pet-Ether) 
41 µg/ml No Effect No Effect No Effect No Effect 
rohituka    
(MeOH) 
No Effect No Effect No Effect No Effect No Effect 
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3.6 Figures 
 
 
Figure 3.1.  Cell viability results for breast cancer cell lines, (a) MCF-7 and (b) HTB126, in 
response to treatment with Amoora extracts as assessed by the MTT assay.  The IC50 values for 
MCF-7 in response to the chittagonga Pet-Ether, CHCl3, and rohituka Pet-Ether are ~42 µg/ml, 
48 µg/ml, and 41µg/ml, respectively.  For HTB126, only the chittagonga CHCl3 induced 
cytoxicity at an IC50 of ~43 µg/ml.  
 
 
(a) 
(b) 
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Figure 3.2.  Cell viability results for pancreatic cancer cell lines (a) Panc-1 and (b) Mia-Paca2, 
in response to treatment with Amoora compounds as assessed by the MTT assay. Of the five 
Amoora extracts, only the chittagonga CHCl3  extract induced cytoxicity in the two pancreatic 
cancer cell types, with the IC50 values of ~39 µg/ml and 30 µg/ml. 
 
(a) 
(b) 
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Figure 3.2 continued.  Cell viability results for pancreatic cancer cell line (c) Capan-1 in 
response to treatment with Amoora compounds as assessed by the MTT assay. Of the five 
Amoora extracts, only the chittagonga CHCl3  extract induced cytoxicity in this cell line, with the 
IC50 values of 65 µg/ml. 
 
 
 
 
(c) 
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Figure 3.3. Cell viability results for MCF-7 cells in response to Amoora compounds using 
photonic crystal biosensor assay. These results are consistent with the results obtained using the 
MTT assay.  The IC50 values of the three extracts, chittagonga Pet-Ether, CHCl3, and rohituka 
Pet-Ether are ~40 µg/ml, 51 µg/ml, and 38 µg/ml, respectively. 
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Figure 3.4.  Correlation between the values of MCF-7 cell viability obtained with the photonic 
crystal assay and the MTT assay for  A.chittagonga (Pet-ether and MeOHextract), and 
A.rohituka (Pet-ether extract). There is high correlation between results from both methods. 
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CHAPTER 4 
PLANT PROTEINS AS AGENTS OF CYTOTOXICITY  
 
4.1 Introduction 
Plant extracts continue to play an important role in the world of drug discovery. They 
have been especially critical to the development of some commercial cancer therapeutics.  Of 
special interest are the medicinal properties of plant proteins and peptides which often are the 
active ingredients of plant based therapeutics. However, the isolation and purification of a 
protein from a crude sample is a time consuming and often expensive process with low yields. 
Furthermore, in cases where there is a limited supply of the crude sample, prohibitively low 
yields can hamper the discovery process. Traditional colorimetric cell proliferation assays are 
usually used to screen a library of samples and rapidly identify therapeutic leads. However, the 
reagents of these colorimetric kits often interact with several salts and buffers (eg. Ammonium 
sulfate, Bis-Tris, EDTA) that are routinely used in the sample preparation and purification steps.  
The presence of such interferants can affect the optical property that is measured to quantify cell 
proliferation. A photonic crystal cell based assay is uniquely suited for testing crude plant 
peptide samples since this label free method does not use any staining reagents.  In this work, we 
performed a preliminary analysis on a collection of crude Pakistani medicinal plant extracts for 
their value as potential pancreatic cancer therapeutics. In this chapter, I have outlined the 
progress made so far in the on-going study of twenty three plant extracts used in eastern folk 
medicine that were obtained from our collaborating lab in Pakistan.  
 
42 
 
4.2 Method and Results:  
We first developed a protocol for the purification of the plant samples. The samples 
received from Pakistan contained proteins that were extracted from seeds of different plants. 
Using an ammonium sulfate salting out process, the plant proteins and peptides were extracted 
from the plant sample. The names of all the plants tested are listed in Table 4.1. These protein 
extracts were further purified in the US to remove any undissolved low molecular weight 
impurities and ammonium sulfate residues that remained from the extraction process. After the 
purification process, the protein concentrations of all extracts were determined. The 
concentration of the final sample was determined using the Bradford assay. Extracts with a low 
protein yield or those that were unstable (indicated by poor result repeatability) were identified 
and removed from further study. In this manner, six of the twenty three extracts were excluded 
from further studies.  
The remaining seventeen extracts were studied for their cytotoxic effects on a human 
pancreatic cancer cell line (Panc-1). All extracts were then tested on Panc-1 pancreatic cancer 
cell cultures at a concentration of 100 µg/mL . A cell proliferation assay was designed and 
performed to identify any extracts that killed these cancer cells. In this assay the fraction of cells 
treated with an extract as compared to untreated cells was used to determine if that extract was 
cytotoxic to the cells. Details of this assay protocol have been previously described in pages 12-
13.  
The results of this screen are shown in Figure 4.1. Six extracts were found to have no 
cytotoxic effects on Panc-1 cells (i.e. fraction of cell survival ≥1).  Five extracts were found to be 
mildly cytotoxic (fraction of cell survival > 0.8).  The remaining six extracts were found to be 
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cytotoxic (fraction of cell survival < 0.5) of which two were extremely cytotoxic (fraction of cell 
survival = 0). The four most cytotoxic extracts were identified as: 
Extract No. 2:  Atropa acuminate (Mako)  
Extract No. 14:  Momordica charantica L (Karela) 
Extract No. 7: Cassia Fistula (Amaltas)  
Extract No. 21: Withania somnifera (Asghand Shereen) 
The above four extracts were tested three separate times and displayed repeatable levels 
of cytotoxicity in these trials. Dose response studies of the four most cytotoxic extracts showed 
that these extracts behave in a concentration dependant fashion.  W. somnifera (No. 21) and A. 
acuminate (No. 2) were found to be most potent at killing Panc-1 cells with low IC50 values of 
6.4 µg/ml and 38.4 µg/ml. 
4.3 Future Direction:  
Our collaborators in Pakistan are currently working on fractionating the four extracts we 
have identified in our cell based screen. This is necessary for the next step in this drug discovery 
process which is to identify and characterize the active components in these plant samples that 
are responsible for the cytotoxicity effects we have observed. It will also be necessary to test 
these extracts on a broad panel of cancerous and normal cell types to assess the specificity with 
which these extracts induce cell death.  Future work will also focus on the elucidation of the 
mechanistic pathways involved in the induction of cell cytotoxcity. 
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4.4 Tables 
Table 4.1. The names of the 23 plant extracts that were tested are listed here. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Extract No. Sa       Samples name 
1. Allium cepa (Onion) 
2. Atropa acuminate (Mako) 
3. Azadirachta indica (Neem) 
4. Berberius aristata (Chitrak) 
5. Brassica  junacea (Sarson) 
6. Brassica rapa (Turnip) 
7. Cassia Fistula (Amaltas) 
8. Citrulus colocynthis (Indraen) 
9. Croton tiglium (Jamal Goota) 
10. Cuminum cyminum (Cumin) 
11. Foenicum vulgare (Badyan) 
12. Hordeom vulgar (Barley,Jao) 
13. Hyoscyannus nigar (Ajwaen Kharasani) 
14. Momordica charantica L (Karela) 
15. Nelumbo nucifera (Lotus) 
16. Nigella sativa (Kalonji) 
17. Papaver somniferum (Khashkass) 
18. Phaseolus vulgaris(Lobia) 
19. Rauwolfia serpentine(Choti-chandan) 
20. Trachyspermum ammi (Ajwain desi) 
21. Withania somnifera (Asghand Shereen) 
22. Zingibar officinalis (Adrak) 
23. Zizyphus vulgans (Unnab) 
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4.5 Figures 
 
Figure 4.1. 17 plant extracts screened for their ability to induce Panc-1 cell death. Four extracts 
induced >95% cell death in Panc-1 cells when tested at 100ug/ml.  
 
46 
 
CHAPTER 5 
PROTEIN-DNA INTERACTION ASSAY 
 
5.1 Introduction:  
High-throughput screening (HTS) is crucial to drug discovery process as the number of 
compounds that are being screened per target has steadily increased. Currently 100,000 and more 
discrete chemical compounds are often being screened against specific targets. Miniaturizing 
HTS has focused on increasing plate density (1536 and 3072 well plates) or on systems like 
Abbott’s arrayed compound screening (microarrayed compound screening system 
µARCSTM).However all these systems use substrates to provide easily quantified chromgenic or 
fluorescent readout. Furthermore, most of these systems are designed for the screen of small 
molecules that are enzyme inhibitors. While many successful drug leads have been found 
through such enzyme inhibition screens, HTS for identifying small molecule inhibitors of 
protein-macromolecule interactions are also of great value.  For example, protein-DNA 
interactions play a crucial role in several cell processes such as transcription, DNA damage 
repair and apoptosis.  Identifying small molecule disruptors of these interactions could have 
value both in the area of investigating these biological processes as well identifying potential 
therapeutics. The Electrophoretic mobility shift assay is a common method available for studying 
DNA-protein interactions. However, this assay is time consuming and does not lend itself to a 
HTS of 100,000 compounds.  Fluorescence polarization has been successfully utilized in HTS 
with the goal of identifying inhibitors of protein-DNA interactions [39,40].  However this 
method does not have the necessary sensitivity to detect interactions where the protein has a low 
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affinity for the DNA strand and the method fails if the protein itself is autofluorescent in an assay 
where the DNA is tagged. 
In this work a label-free PC based assay has been designed for the multiplexed, high-
throughput screening of inhibitors that disrupt binding between protein –DNA interactions that 
are sequence independent. In this screen approximately 175,000 compounds were evaluated. We 
looked specifically at the human apoptosis inducing factor (AIF), a protein that binds 
nonspecifically to chromosomal DNA. AIF, a 67kDa cytoplasmic protein plays a key role in 
caspase-independent cell death [41,42]. Small molecule inhibitors of the AIF-DNA interaction 
are of great interest due to the involvement of AIF in multiple disease state models like 
Parkinson’s disease [43]; however, no small molecule inhibitors of AIF-DNA interaction have 
been reported. 
5.2 Methods: 
For this work, we used PC biosensors that are incorporated into 384-well plates. A 
detailed description of the structure and working of this sensor is presented on page 8.  A readout 
instrument (SRU Biosystems BIND Reader), separate from the imaging instrument discussed 
previously, is used for this work. The instrument illuminates microplate wells from below with a 
broadband light source coupled to eight optical fibers, each illuminating a ~ 2mm diameter 
region of the PC surface at normal incidence. Reflected light is collected by a second optical 
fiber, bundled next to the illuminating fiber, and measured by a spectrometer. An automated 
motion stage enables parallel collection of reflectance data at timed intervals to acquire kinetic 
information from all 384 wells.  The experimental setup of the DNA-binding assays performed 
using the PC biosensor is illustrated in Figure 5.1. 
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Biotinlayted 30bp DNA oligomers (1 µM) were immobilized on a 384-well streptavidin 
coated sensor plate. After a 12 h incubation period at 4oC, any unbound DNA was washed away 
and a blocking agent (Starting Block from Pierce Biotechnology) was applied to reduce any 
nonspecific binding between AIF and the sensor surface.  AIF (1.6 mg/mL) was incubated with a 
mixture of 10 putative small molecule inhibitors such that the final concentration of each 
compound was 25 µM. For each experimental well, a reference well was created on the same 
plate that was identical to the experimental well except that is lacked AIF. Two wells on each 
biosensor microplate (plus two reference wells that lacked AIF) are utilized for a positive control 
for competition with the DNA oligonucleotide (50 µM of non-biotinlyated DNA). Two 
additional wells on each biosensor microplate (plus two reference wells that lacked AIF) are 
utilized for a positive control with Aurin Tricarboxylic Acid (ATA, 25 µM), the only small 
molecule identified to inhibit AIF-DNA binding [44]. Finally, two wells (plus two reference 
wells that lacked AIF) were used as negative controls and contained AIF and DMSO (vehicle) 
only. A schematic of the experiment is shown in Figure 5.2. 
After a 30 min incubation of the AIF/compound mixture, these solutions were transferred 
to the DNA-containing 384-well biosensor plate and allowed to incubate for 4 h. Compounds 
that inhibit the AIF- DNA interaction would prevent the PWV shift observed in the AIF-DNA 
binding event. By screening compounds mixed in groups of 10, 1880 compounds were tested per 
plate. Approximately 175,000 compounds were evaluated in this screening campaign. 
5.3 Results and Discussion: 
Data from the screen is shown in Figure 5.3. All experimental wells were normalized 
against the DNA control wells whose PWV shift was set to 100% inhibition and the AIF+DMSO 
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control wells whose PWV shifts were set to 0% inhibition. Any well that displayed inhibition 
over 3 standard deviations removed from the mean were regarded as “hits” in this screen. From 
our data, 18 wells were identified as hits. Furthermore, the control wells with ATA displayed a 
consistent inhibition of ~ 90%. The Z’ factor for this assay was 0.807 ± 0.121 indicating that this 
is a high quality screen [45]. 
The 18 identified wells have been subjected to follow up screens. Each of the 10 
compounds in a well with a “hit” was tested separately to identify the small molecule inhibitor. 
Current work is underway to synthesis compounds that structurally similar to the “hit 
compounds” but display increased specificity in disrupting the AIF-DNA binding. Future work 
will involve testing the synthesized products in cell based assays. 
The PC biosensor method can easily be adapted for analogous experiments with protein-
RNA and protein-protein interacts. It is also possible to design assays where the PC surface can 
be functionalized to capture histidine tagged proteins. The benefits of such a method for protein-
protein assays are two-fold.  First, the design, production, and purification of a recombinantly 
expressed his-tagged protein are much easier and more widespread than the production of a 
biotinylated protein. Furthermore, the protein-protein complex bound to the sensor surface can 
be eluted with imidazole that allows for the regeneration and reuse of the sensor surface. In 
conclusion, we have demonstrated that the photonic crystal biosensor assay is well suited for 
rapidly identifying small molecule inhibitors of protein-DNA interactions with applications in 
the development of therapeutics for neurodegenerative diseases like Parkinson’s. 
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5.4 Figures 
 
 
Figure 5.1. Schematic of the PC sensor and readout instrumentation. A broadband LED 
illuminates the biosensor from the bottom, and reflected light is collected and transferred to a 
spectrometer where the PWV is measured. 
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Figure 5.2. Schematic of the protein-DNA experiment performed. Streptavidin-coated 
biosensors are used to bind biotinlyated DNA oligomers, and a distinct peak wavelength of the 
reflected light is observed. Simultaneously, DNA-binding protein, AIF is premixed with 10 small 
molecule compounds in a separate clear-bottom plate. After the addition of the blocker to the 
biosensor, the incubated mix of protein and small molecules is added to the sensor. A shift in the 
wavelength of reflected light is observed. If an inhibitor is present in the mix of 10 compounds, a 
very small shift is observed, indicating the disruption of AIF-DNA binding.  
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Figure 5.3. Approximately 175,000 compounds were evaluated for their ability to inhibit AIF-
DNA interaction using photonic crystal biosensors. Positive controls with DNA (white circles) 
were performed on each plate and set at 100% inhibition. The results from the control ATA (a 
known AIF-DNA inhibitor) are shown as red circles. 
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CHAPTER 6 
CONCLUSION 
 
In this thesis two main applications of label-free photonic crystal biosensors have been explored. 
First, a cell-based assay using as few as 500 cells per well was designed and used to screen two 
separate libraries of plant based compounds. Compounds that were cytotoxic to a panel of cancer 
cell lines were identified. Further analysis of one such compound - Petunia Punctata, revealed 
that this compound induced cell death via apoptosis. Furthermore the cyototoxic potential of 
plant based compounds extracted through different methods was explored. We found that the 
method of extraction affected the cytotoxic potential of two species from the genus Amoora on a 
panel of five cancer cell lines. 
A second application of photonic crystal biosensors to a protein-DNA binding assay was also 
presented. The objective of this assay was to identify small molecule compounds that disrupted 
the binding between DNA oligomers and a protein called apotosis inducing factor, AIF. A screen 
of 175,000 small molecules was performed and 20 leads were identified. These leads are now 
being studied for their efficacy as potential therapeutics for Parkinson’s disease. 
The strength of the photonic crystal sensor lies in its wide found applications in high throughput 
binding affinity, specificity, and kinetics assays. With an increasing number of targets emerging 
from genomics and proteomics methods, an efficient platform that accurately identifies drug 
leads is crucial.  While label-based methods continue to find applications in advanced stages of 
the drug discovery process, label-free sensing that can be adapted to commonly used labware is 
poised to become the more popular choice in preliminary pharmaceutical drug screens where 
high throughtput and low cost are key necessities. 
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